Moxifloxacin HCL 400 MG tablet UD 50S
Ended Awarded
- Contract number
- SPE2DX25FY3RZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $2,001
Award facts
- Contract value 100% obligated
- $2,001.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Moxifloxacin HCL 400 mg tablets in unit dose packaging of 50 units. The contract, valued at $2,001.00, is structured as a firm fixed price delivery order with an ultimate completion date of August 1, 2025. The award was made through open competition without set-aside designation, and performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, a $999.999 billion comprehensive global pharmaceutical support vehicle running through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated substantial capability as a federal medical supply vendor through its extensive portfolio of competitively awarded contracts with the Defense Logistics Agency and Medical Supply Chain. The company supplies a comprehensive range of pharmaceutical products supporting military and veteran healthcare systems, including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The firm fixed pricing structure and rapid completion timeline reflect the routine nature of pharmaceutical delivery orders within the broader Pharmaceutical Prime Vendor Global Program framework that supports the Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DX25FY3RZ?
SPE2DX25FY3RZ was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on July 31, 2025.
How much is contract SPE2DX25FY3RZ worth?
The government has obligated $2,001 on SPE2DX25FY3RZ.
Is contract SPE2DX25FY3RZ an order under another contract?
Yes. SPE2DX25FY3RZ is a delivery order under SPE2DX15D6905, an indefinite delivery contract.
Was contract SPE2DX25FY3RZ competed?
The extent of competition for SPE2DX25FY3RZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award